Globus Medical price to free cash flow GMED

Market value divided by free cash flow over the last twelve months, since 2013.

Today, Oct 23, 2026: 14.5×
10-year median: 40.6×
Against its 10-year history: 2nd; percentile: 0 is its lowest day, 100 its highest
10-year range: 13.2× to 67.4×
Peer median: 19.8×

Globus Medical's price to free cash flow is 14.5× as of Oct 23, 2026.

That is below its ten-year median of 40.6×, lower than on 98% of days in the last ten years.

Over that time it ranged from 13.2× in Sep 2026 to 67.4× in Feb 2023.

The median for 10 medical instruments and supplies stocks of a similar size is 19.8×.

Price to free cash flow over time

median 40.6×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	14.5×	13.2×	21.9×
2025	20.4×	13.6×	43.0×
2024	38.7×	37.5×	64.7×
2023	56.9×	37.9×	67.4×
2022	62.8×	28.5×	63.4×
2021	32.4×	28.3×	62.2×
2020	59.8×	36.7×	64.5×
2019	65.2×	31.2×	65.2×
2018	33.5×	32.6×	52.3×
2017	34.6×	19.3×	34.6×
2016	19.3×	16.5×	71.1×
2015	77.6×	25.0×	77.6×
2014	25.8×	20.2×	44.1×
2013	34.2×	28.7×	38.9×

Against its peers

Companies in Medical - Instruments & Supplies nearest Globus Medical's size, closest first, today.

Company	Price to free cash flow
GMEDGlobus Medical	14.5×
ALGNAlign Technology	17.3×
PODDInsulet	35.2×
COOCooper Companies	17.2×
PENPenumbra	59.2×
SOLVSolventum	n/m
MSAMSA Safety	19.8×
MMSIMerit Medical Systems	27.4×
HAEHaemonetics	18.5×
VNTVontier	12.1×
BMIBadger Meter	29.2×
Peer median	19.8×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Globus Medical

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.